MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatology Biotech Investing
Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2016 Financial Results Biotech Investing
ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation Life Science Investing
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib Life Science Investing
